Rebalix
Logo UBSUBS · sheet of 10 September 2026
ETF sheet · official issuer and register data

UBS Solactive China Technology UCITS ETF USD acc

LU2265794276 · LU2265794276 · USD · domicile Luxembourg
Equity · China · TechnologySFDR art. 6
Index tracked: Solactive China Technology (NTR)
TER
0.47%+ trans. 0.06%
Fund size
216 m EUR
Tracking difference
−0.44%3-year avg
🇮🇹 tax rate
26.00%white list 0.00%
Replication
Physical (full replication)
Income
Accumulating
Launch 5 Mar 2021 · costs from the KID as of 2 Sept 2026 · 0 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 5 Aug 2026
The Fund is passively managed and will take proportionate exposure on the components of the Solactive China Technology Index (Net Return) using a sampling strategy which invests in a representative sample of constituent stocks of the index selected by the investment manager using quantitative analytical models in a technique known as 'portfolio optimization'. The sub-fund can also make use of derivatives in particular where it may not be possible or practicable to replicate the index through direct investments or in order to generate efficiencies in…

Performance since series start (in euro) — base 100

5 Mar 20218 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
202220232024202520261033755
High 103 (11 Mar 2021) · low 37 (2 Feb 2024) · last 55. Past performance is not indicative of future results.

Returns in euro

1 year−19.8%
3 years+13.6%
5 years−32.6%
10 yearsseries too young
Since series start−44.9%

Risk · 1 / 3 / 5 years

Volatility (ann.)26.88%29.93%35.34%
Max drawdown−31.62%−31.62%−60.03%
Sharpe-0.880.28-0.13
Sortino-1.200.39-0.20
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LU2265794276 · LU22657942761
RebalixLU2265794276 · LU2265794276 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+41.34%+41.76%−0.42%
2024+10.85%+11.32%−0.47%
2023−10.43%−9.99%−0.44%
2022−31.86%−31.67%−0.19%

Holdings

Portfolio as declared by the issuer · 31 Jul 2026 · 0 securities · top-10 weight = 61.1%
Top holdingsWeight
ALIBABA GROUP HOLDING LTD10.2%
TENCENT HOLDINGS LTD10.0%
MEITUAN8.8%
XIAOMI CORP8.6%
NETEASE INC6.3%
BYD CO LTD6.0%
BAIDU INC-CLASS A3.9%
Z.AI CO., LTD.2.6%
WUXI BIOLOGICS CAYMAN INC2.4%
INNOVENT BIOLOGICS INC2.3%
Sectors (% of fund)
Beni di consumo30.2%Servizi di comunicazione24.0%Tecnologia dell'informazio…22.9%Sanità12.8%Industriali5.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
CIT · Borsa Italiana (ETFplus)
UIC2 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 19 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.ubs.com/2/e/priip/PRIIPSEU_LU2265794276_en_IE.pdf
Factsheet · www.ubs.com/2/e/files/RET/FS_RET_LU2265794276_IT_IT.pdf
Prospectus · www.ubs.com/2/e/files/lux_etf_pe.pdf
The live sheet, always up to date
rebalix.com/en/etf/LU2265794276
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LU2265794276 · LU22657942762